Contribution of IL-13 to early exocrinopathy in Id3 -/- mice

Molecular Immunology

Volumn 49, Issue 1-2, 2011, Pages 227-233

  Mahlios, Josh ^a   Zhuang, Yuan ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Exocrinopathy; Id3 deficient mice; IL 13; Mast cells

Indexed keywords

CYTOKINE; INTERLEUKIN 13; INTERLEUKIN 13 ANTIBODY; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXOCRINE GLAND; EXOCRINOPATHY; LYMPHOCYTIC INFILTRATION; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SALIVATION; SJOEGREN SYNDROME; SYMPTOM; T LYMPHOCYTE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; INHIBITOR OF DIFFERENTIATION PROTEINS; INTERLEUKIN-13; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SJOGREN'S SYNDROME;

MUS;

EID: 82455179445     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2011.08.012     Document Type: Article

References (26)

1. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 2002, 61:554-558.
2. Voulgarelis M., Tzioufas A.G. Pathogenetic mechanisms in the initiation and perpetuation of Sjogren's syndrome. Nat. Rev. Rheumatol. 2010, 6:529-537.
3. Fox R.I., Stern M., Michelson P. Update in Sjogren syndrome. Curr. Opin. Rheumatol. 2000, 12:391-398.
4. Katsifis G.E., Moutsopoulos N.M., Wahl S.M. T lymphocytes in Sjogren's syndrome: contributors to and regulators of pathophysiology. Clin. Rev. Allergy Immunol. 2007, 32:252-264.
5. Hansen A., Lipsky P.E., Dorner T. B cells in Sjogren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue. Arthritis Res. Ther. 2007, 9:218.
6. Jonsson M.V., Delaleu N., Jonsson R. Animal models of Sjogren's syndrome. Clin. Rev. Allergy Immunol. 2007, 32:215-224.
7. Li H., Dai M., Zhuang Y. A T cell intrinsic role of Id3 in a mouse model for primary Sjogren's syndrome. Immunity 2004, 21:551-560.
8. Guo Z., Li H., Han M., Xu T., Wu X., Zhuang Y. Modeling Sjogren's syndrome with Id3 conditional knockout mice. Immunol. Lett. 2011, 135:34-42.
9. Katsifis G.E., Rekka S., Moutsopoulos N.M., Pillemer S., Wahl S.M. Systemic and local interleukin-17 and linked cytokines associated with Sjogren's syndrome immunopathogenesis. The American Journal of Pathology 2009, 175:1167-1177.
10. Wynn T.A. IL-13 effector functions. Annu. Rev. Immunol. 2003, 21:425-456.
11. McKenzie A.N., Culpepper J.A., de Waal Malefyt R., Briere F., Punnonen J., Aversa G., et al. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:3735-3739.
12. Punnonen J., Aversa G., Cocks B.G., McKenzie A.N., Menon S., Zurawski G., et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:3730-3734.
13. Emson C.L., Bell S.E., Jones A., Wisden W., McKenzie A.N. Interleukin (IL)-4-independent induction of immunoglobulin (Ig)E, and perturbation of T cell development in transgenic mice expressing IL-13. J. Exp. Med. 1998, 188:399-404.
14. Mohrs M., Ledermann B., Kohler G., Dorfmuller A., Gessner A., Brombacher F. Differences between IL-4- and IL-4 receptor alpha-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling. J. Immunol. 1999, 162:7302-7308.
15. McKenzie G.J., Emson C.L., Bell S.E., Anderson S., Fallon P., Zurawski G., et al. Impaired development of Th2 cells in IL-13-deficient mice. Immunity 1998, 9:423-432.
16. Yang M., Hogan S.P., Henry P.J., Matthaei K.I., McKenzie A.N., Young I.G., et al. Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-alpha chain and STAT-6 independently of IL-5 and eotaxin. Am. J. Respir. Cell Mol. Biol. 2001, 25:522-530.
17. Fallon P.G., Richardson E.J., McKenzie G.J., McKenzie A.N. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J. Immunol. 2000, 164:2585-2591.
18. Spadaro A., Rinaldi T., Riccieri V., Taccari E., Valesini G. Interleukin-13 in autoimmune rheumatic diseases: relationship with the autoantibody profile. Clin. Exp. Rheumatol. 2002, 20:213-216.
19. Villarreal G.M., Alcocer-Varela J., Llorente L. Differential interleukin (IL)-10 and IL-13 gene expression in vivo in salivary glands and peripheral blood mononuclear cells from patients with primary Sjogren's syndrome. Immunol. Lett. 1996, 49:105-109.
20. Mitsias D.I., Tzioufas A.G., Veiopoulou C., Zintzaras E., Tassios I.K., Kogopoulou O., et al. The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome. Clin. Exp. Immunol. 2002, 128:562-568.
21. Sayed B.A., Christy A., Quirion M.R., Brown M.A. The master switch: the role of mast cells in autoimmunity and tolerance. Annu. Rev. Immunol. 2008, 26:705-739.
22. Wills-Karp M. Interleukin-13 in asthma pathogenesis. Curr. Allergy Asthma Rep. 2004, 4:123-131.
23. Konttinen Y.T., Hietanen J., Virtanen I., Ma J., Sorsa T., Xu J.W., et al. Mast cell derangement in salivary glands in patients with Sjogren's syndrome. Rheumatol. Int. 2000, 19:141-147.
24. Kaur D., Hollins F., Woodman L., Yang W., Monk P., May R., et al. Mast cells express IL-13R alpha 1: IL-13 promotes human lung mast cell proliferation and Fc epsilon RI expression. Allergy 2006, 61:1047-1053.
25. Gregory G.D., Robbie-Ryan M., Secor V.H., Sabatino J.J., Brown M.A. Mast cells are required for optimal autoreactive T cell responses in a murine model of multiple sclerosis. Eur. J. Immunol. 2005, 35:3478-3486.
26. Gombert M., Dieu-Nosjean M.C., Winterberg F., Bunemann E., Kubitza R.C., Da Cunha L., et al. CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation. J. Immunol. 2005, 174:5082-5091.